Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2010 4
2011 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Epidemiologic perspective on immune-surveillance in cancer.
Cramer DW, Finn OJ. Cramer DW, et al. Curr Opin Immunol. 2011 Apr;23(2):265-71. doi: 10.1016/j.coi.2011.01.002. Epub 2011 Feb 1. Curr Opin Immunol. 2011. PMID: 21277761 Free PMC article. Review.
Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies.
Pinheiro SP, Hankinson SE, Tworoger SS, Rosner BA, McKolanis JR, Finn OJ, Cramer DW. Pinheiro SP, et al. Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1595-601. doi: 10.1158/1055-9965.EPI-10-0068. Epub 2010 May 25. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20501761 Free PMC article.
Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses.
Ryan SO, Turner MS, GariƩpy J, Finn OJ. Ryan SO, et al. Cancer Res. 2010 Jul 15;70(14):5788-96. doi: 10.1158/0008-5472.CAN-09-4519. Epub 2010 Jun 29. Cancer Res. 2010. PMID: 20587526 Free PMC article.
Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.
Kadayakkara DK, Beatty PL, Turner MS, Janjic JM, Ahrens ET, Finn OJ. Kadayakkara DK, et al. Pancreas. 2010 May;39(4):510-5. doi: 10.1097/MPA.0b013e3181bd6501. Pancreas. 2010. PMID: 20084048 Free PMC article.
Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.
Ninkovic T, Kinarsky L, Engelmann K, Pisarev V, Sherman S, Finn OJ, Hanisch FG. Ninkovic T, et al. Mol Immunol. 2009 Nov;47(1):131-40. doi: 10.1016/j.molimm.2008.09.032. Epub 2008 Nov 12. Mol Immunol. 2009. PMID: 19007994 Free PMC article.
Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles.
Pejawar-Gaddy S, Rajawat Y, Hilioti Z, Xue J, Gaddy DF, Finn OJ, Viscidi RP, Bossis I. Pejawar-Gaddy S, et al. Cancer Immunol Immunother. 2010 Nov;59(11):1685-96. doi: 10.1007/s00262-010-0895-0. Epub 2010 Jul 21. Cancer Immunol Immunother. 2010. PMID: 20652244 Free PMC article.
A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.
Lepisto AJ, Moser AJ, Zeh H, Lee K, Bartlett D, McKolanis JR, Geller BA, Schmotzer A, Potter DP, Whiteside T, Finn OJ, Ramanathan RK. Lepisto AJ, et al. Cancer Ther. 2008;6(B):955-964. Cancer Ther. 2008. PMID: 19129927 Free PMC article.